Lead Product(s) : Pentazocine
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase I
Sponsor : National Institute on Aging | Gansu Provincial Maternal and Child Health Care Hospital | National Center for Complementary and Integrative Health | Office of Research on Women's Health | National Center for Advancing Translational Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of a Kappa Agonist on Hot Flashes in Menopausal Women
Details : Pentazocine is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Hot Flashes.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 25, 2014
Lead Product(s) : Pentazocine
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase I
Sponsor : National Institute on Aging | Gansu Provincial Maternal and Child Health Care Hospital | National Center for Complementary and Integrative Health | Office of Research on Women's Health | National Center for Advancing Translational Sciences
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
